Clinical Trial Update: Treatment of Cerebral Radiation Necrosis With GM1, a Prospective Study

View source ↗

Summary

A prospective study evaluating GM1 for cerebral radiation necrosis in nasopharyngeal carcinoma patients after radiotherapy; current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cerebral Radiation Necrosis
• Nasopharyngeal Carcinoma

Drugs mentioned

• GM1 (monosialotetrahexosyl ganglioside)

Snippet

Sponsor: Fudan University | Conditions: Radiotherapy, Nasopharyngeal Carcinoma | Status: UNKNOWN